ID Clinic
- Address
- lock Available on a paid plan
ID Clinic - Hepatology and Liver Disease Research Center
ID Clinic is a specialized medical research center focused on advancing treatments for complex hepatological conditions. The center demonstrates extensive expertise in conducting Phase II and Phase III clinical trials investigating novel therapeutic approaches for chronic liver diseases, including rare cholestatic disorders, metabolic liver conditions, and viral hepatitis.
- Primary sclerosing cholangitis (PSC) and cholestatic liver disease research
- Non-alcoholic steatohepatitis (NASH) and NASH-related cirrhosis complications
- Chronic hepatitis B functional cure investigations
- Cirrhosis management and fluid retention therapies
The research portfolio at ID Clinic encompasses multiple therapeutic modalities, from bile acid derivatives for cholestatic diseases to antifibrotic agents targeting liver fibrosis progression. The center actively investigates prevention strategies for esophageal varices in cirrhotic patients and evaluates innovative combination therapies for managing cirrhosis-related complications. With particular strength in metabolic liver disease research, ID Clinic contributes to long-term follow-up studies assessing durability of treatment responses, particularly in chronic hepatitis B functional cure outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 40 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ID Clinic
lock Showing 1 of 30 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete Radiological Response after Surgical Resection or Local Ablation (KEYNOTE-937) | Merck Sharp & Dohme LLC | Phase III | Not Recruiting | May 2019 | Jul 2025 |
IMP list
lock Showing 1 of 40 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bepirovirsen | 3 | Unknown | 2019-03-28 | 2023-01-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.